EMEA-001045-PIP01-10-M01

  • Email
  • Help

Overview

Product details for Kevzara
Invented nameKevzara
Active substance

sarilumab

Decision numberP/0348/2017
PIP numberEMEA-001045-PIP01-10-M01
Pharmaceutical form(s)Solution for injection
Condition(s)/indication(s)

Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, spondylarthritis, psoriatic arthritis and juvenile idiopathic arthritis)

Route(s) of administrationSubcutaneous use
PIP applicant

Sanofi-Aventis Recherche & Développement
Tel. +33 169745695
E-mail: contact-us@sanofi.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision

Related information